Haart
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
450 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | 49 | 77 | 47 | 60 | 134 | 348 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 9 | 19 | 13 | 16 | 39 | 90 |
| Hiv | D006678 | — | — | 8 | 12 | 5 | 10 | 36 | 69 |
| Infections | D007239 | EFO_0000544 | — | 13 | 16 | 8 | 11 | 21 | 62 |
| Communicable diseases | D003141 | — | — | 7 | 7 | 4 | 3 | 14 | 31 |
| Immunologic deficiency syndromes | D007153 | HP_0002721 | D84.9 | 2 | 4 | 1 | 6 | 15 | 27 |
| Hepatitis | D006505 | HP_0012115 | K75.9 | 1 | 1 | 5 | 2 | 4 | 13 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | 3 | 2 | 2 | 5 | 13 |
| Lipodystrophy | D008060 | HP_0009125 | E88.1 | — | 4 | — | 6 | 1 | 11 |
| Hiv-1 | D015497 | — | — | 2 | 3 | — | 2 | 1 | 8 |
Show 39 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | 1 | 4 | — | 3 | 9 |
| Hepatitis c | D006526 | — | B19.2 | 1 | 1 | 5 | — | 1 | 8 |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | 2 | — | — | 2 |
| Immune reconstitution inflammatory syndrome | D054019 | — | — | — | — | 1 | — | 1 | 2 |
| Fever | D005334 | HP_0001945 | R50.9 | — | — | 1 | — | 1 | 2 |
| Yellow fever | D015004 | — | A95 | — | — | 1 | — | 1 | 2 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 1 | — | — | 1 |
| Heroin dependence | D006556 | EFO_0004240 | — | — | 1 | 1 | — | — | 1 |
| Chronic hepatitis | D006521 | — | K73.9 | — | — | 1 | — | — | 1 |
| Disease progression | D018450 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperlipidemias | D006949 | HP_0003077 | E78.5 | 1 | 2 | — | — | 3 | 5 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 2 | — | — | 1 | 3 |
| Aids-related lymphoma | D016483 | EFO_1001365 | — | 2 | 1 | — | — | — | 3 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | 1 | — | — | 2 | 3 |
| Metabolic bone diseases | D001851 | HP_0000938 | — | — | 1 | — | — | 2 | 3 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | 1 | 2 |
| Hyperlipoproteinemias | D006951 | HP_0010980 | — | — | 1 | — | — | 1 | 2 |
| Osteoporosis | D010024 | HP_0000939 | M81.0 | — | 1 | — | — | 1 | 2 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | 2 | — | — | — | 2 |
| Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | 2 | 3 |
| Recurrence | D012008 | — | — | 2 | — | — | — | 1 | 3 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | 1 | 2 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | — | — | — | — | 2 |
| Hodgkin disease | D006689 | — | C81 | 2 | — | — | — | — | 2 |
| Pneumococcal infections | D011008 | EFO_0000772 | J13 | 1 | — | — | — | 1 | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | — | — | 1 |
| Mycoses | D009181 | — | B35-B49 | 1 | — | — | — | — | 1 |
| Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
Show 55 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 5 | 5 |
| Aortic valve insufficiency | D001022 | EFO_0007148 | — | — | — | — | — | 4 | 4 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 3 | 3 |
| Mycobacterium avium-intracellulare infection | D015270 | EFO_0007386 | — | — | — | — | — | 2 | 2 |
| Mycobacterium infections | D009164 | — | A31.9 | — | — | — | — | 2 | 2 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | — | 2 | 2 |
| Retinitis | D012173 | — | H30.9 | — | — | — | — | 2 | 2 |
| Opportunistic infections | D009894 | — | — | — | — | — | — | 1 | 1 |
| Calcium metabolism disorders | D002128 | EFO_0005769 | E83.5 | — | — | — | — | 1 | 1 |
| Cd4 lymphocyte count | D018791 | — | — | — | — | — | — | 1 | 1 |
Show 46 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use